Precigen, Inc. PGEN
Set alert
5.13 USD -0.01 -0.19%
As of Nov 3, 11:16 AM ET
5.08 Day range 5.38
3.04 52-week range 8.98
- YTD
- +22.73%
- 1 year
- +23.32%
- Open
- 5.31
- Prev close
- 5.14
- Mkt cap
- 1.83B
- Vol
- 2.39M
- Avg vol
- 5.50M
- EPS
- -1.04
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.08
- High
- 5.38
- Forward P/E
- -23.36
- Beta
- 0.98
- Short ratio
- 8.53
- Inst. own
- 72.89%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 7.22
- 200-d avg
- 5.27
- 1y target
- 13.65
MAX chart
Events in this range
- Aug 3, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Aug 4, 2026Earnings: 0.05; estimate -0.01207; surprise 514.25%
- Aug 5, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Nov 4, 2026Earnings: —; estimate 0.06; surprise —%
Signals (47)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 2026 | 19 hours ago |
| RSI: Overbought | Jun 1, 2026 | 5 months ago |
| RSI: Overbought | Aug 1, 2025 | 1 year ago |
| SMA: Bullish | Feb 1, 2025 | 1 year ago |
| SMA: Bullish | Jan 1, 2025 | 1 year ago |
| SMA: Bearish | Aug 1, 2024 | 2 years ago |
| SMA: Bearish | Aug 1, 2024 | 2 years ago |
| SMA: Bullish | Jun 1, 2024 | 2 years ago |
| SMA: Bullish | May 1, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Dec 1, 2023 | 2 years ago |
| SMA: Bearish | Oct 1, 2023 | 3 years ago |
| SMA: Bullish | Jul 1, 2023 | 3 years ago |
| SMA: Bearish | Dec 1, 2022 | 3 years ago |
| SMA: Bullish | Nov 1, 2022 | 4 years ago |
| MACD: Buy Signal | Nov 1, 2022 | 4 years ago |
| SMA: Bearish | Oct 1, 2022 | 4 years ago |
| SMA: Bullish | Sep 1, 2022 | 4 years ago |
| MACD: Sell Signal | Nov 1, 2021 | 5 years ago |
| SMA: Bearish | Sep 1, 2021 | 5 years ago |
Newest 20 of 47.
Financial health
Altman Z-Score
-12.06 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -3.0×
FY 2016 5y median -3.4× FY 2025
P/S 132×
FY 2016 5y median 52.6× FY 2025
P/B 60.9×
FY 2016 5y median 6.8× FY 2025
P/FCF -14.2×
FY 2016 5y median -4.8× FY 2025
EV/EBITDA -5.5×
FY 2016 5y median -5.5× FY 2025
EV/Sales 139×
FY 2016 5y median 62.2× FY 2025
FCF Yield -7.1%
FY 2016 5y median -20.9% FY 2025
Profitability
Gross Margin 37.1%
FY 2016 5y median 1.7% FY 2025
Operating Margin -1100.8%
FY 2016 5y median -1100.8% FY 2025
Net Margin -2588.2%
FY 2016 5y median -1540.6% FY 2025
ROE -1198.6%
FY 2016 5y median -85.9% FY 2025
ROIC -88.5%
FY 2016 5y median -76.8% FY 2025
ROA -160.0%
FY 2016 5y median -63.5% FY 2025
Growth (YoY)
Revenue 146.7%
FY 2016 FY 2025
Operating Income 21.1%
FY 2016 FY 2025
EPS (diluted) -200.0%
FY 2016 FY 2025
Free Cash Flow -17.0%
FY 2016 FY 2025
Financial Health
Current Ratio 3.1×
FY 2016 5y median 3.1× FY 2025
Quick Ratio 2.8×
FY 2016 5y median 3.0× FY 2025
Debt / Equity 4.7×
FY 2016 5y median 0.4× FY 2025
Net Debt / EBITDA -0.3×
FY 2016 5y median -0.3× FY 2025
Interest Coverage -27.6×
FY 2016 5y median -27.6× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
